Patients with neurodegeneration of the basal forebrain are predominantly treated with acetylcholinesterase (AchE) inhibitors to suppress the cognitive decline and to improve the memory (Birks, 2006; Rolinski et al., 2012). Here, ACHE is linked to Mental deterioration.